The Impact of Serums Calcium 25-Hydroxy Vitamin D, Ferritin, Uric Acid, and Sleeping Disorders on Benign Paroxysmal Positional Vertigo Patients.

OBJECTIVE

This study's objective was to identify the factors and impact of serums calcium 25-Hydroxy vitamin D, ferritin, uric acid, and sleeping disorders on benign paroxysmal positional vertigo (BPPV) patients.

METHODS

This is a case and control design study. The consecutive patients' visits (age, older than 25 years) with idiopathic BPPV were recruited in the present study. For each patient, 3:1 sex and age-matched healthy people were assigned as the control. The study comprised 177 patients with BPPV and 656 controls. The study included biochemical, clinical, physical examinations, PSQI sleep quality, supine roll test, and Dix-Hallpike test for the diagnosis of all patients, and pure-tone audiometry (PTA) was used to assess hearing. Univariate and multivariate stepwise regression analyses were used for statistical analysis.

RESULTS

The study comprised 833 patients with 295 males (35.4%) and 538 females (64.6%) who were between 25 and 70 years old. Of a total of 833 participants, 177 were BPPV patients, and 656 subject were normal. The results shown that there were significant differences between the BPPV and the normal group in terms of BMI ( = 0.039), physical activity ( = 0.003), cigarette smoking ( = 0.035), nargile-waterpipe use ( < 0.001), diabetes ( < 0.001), hypertension ( < 0.001), congestive heart failure (CHF) ( < 0.001), neurology ( < 0.001), tinnitus ( < 0.001), dizziness ( < 0.001), headache ( < 0.001), vitamin D ( = 0.004), calcium ( = 0.004), magnesium ( < 0.001), potassium ( = 0.019), phosphorus ( < 0.001), haemoglobin ( < 0.001), serum glucose ( < 0.001), HbA1c ( < 0.001), triglyceride ( < 0.001), systolic BP ( = 0.004), diastolic BP ( = 0.008), and microalbuminuria ( = 0.005); ATP III metabolic syndrome ( = 0.038), IDF metabolic syndrome ( = 0.034), and poor sleep ( = 0.033). In terms of the type of BPPV, the posterior canal was the most commonly affected ( = 126, 71.2%), followed by the horizontal ( = 43, 24.3%) and anterior canal ( = 8, 4.5%). The analysis indicated that serum ferritin ( < 0.001), uric acid ( < 0.001), blood pressure ( < 0.001), dizziness ( < 0.001), cigarette-water-pipe smokers ( = 0.004), headaches/migraines ( = 0.005), calcium ( = 0.007), vitamin D deficiency ( = 0.008), sleepiness ( = 0.016), physical activity ( = 0.022), CHF ( = 0.024), and tinnitus ( = 0.025) were considered as risk predictors for BPPV.

CONCLUSIONS

The results revealed that the serum levels of vitamin D, ferritin, uric acid, and calcium are low among the study population and supplementation could be considered as prevention in BPPV patients.